ArticleAMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science2025
Feasibility of Automated Precharting using GPT-4 in New Specialty Referrals.
Article in AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Artificial Intelligence-Generated Electronic Medical Record Summarization in Breast Surgical Oncology.Annals of surgical oncology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study evaluates the feasibility of using GPT-4 to automate precharting for specialty referrals, focusing on new patients referred to an otolaryngology clinic for nasal congestion. We describe the design decisions and strategies tested in creating this precharting utility, including methods for prompt design and token limit handling. Through iterative testing and building, our tool achieved 95.0% agreement with physician consensus in a small retrospective test sample. Results from a small prospective pilot showed favorable feedback of summaries in a real-world clinical setting, though there was a discrepancy between high intention to use the summary but lower perception of time savings. Our results demonstrate that automated pre-charting with accuracy and clinical relevance can be feasible with large language models such as GPT-4. Our design features can inform the development of vendor chart summarization solutions.
Identifiers
40502261PMC12150724What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.